Important: By clicking “Yes” you are confirming that you are a healthcare professional. OncosilTM is currently unapproved for commercial sale in your region. If you are not a healthcare professional then please click here to Go to the Homepage.
Intended Use & Indications
OncoSil™ is intended for intratumoural implantation into a pancreatic tumour via injection under Endoscopic Ultrasound (EUS) guidance.
Indications for Use
Oncosil™ is indicated for the treatment of patients with advanced unresectable pancreatic cancer, in combination with standard of care chemotherapy.